This morning, Hoffman had just walked into his headquarters office in Leverkusen, and as usual, he glanced at the work arrangement that his secretary had given him, and everything else was normal, except that when he saw the last thing, his brow furrowed unconsciously, and then he called his secretary: "Tony, what's the matter with this Indian?"

Secretary Tony hurriedly replied respectfully: "Boss, there is a Mr. Shakru Pandit from India who wants to buy a scientific research and research patent from us. ”

As soon as he heard this, Hoffman snorted coldly and said: "They Indians still know that there is such a thing as a patent in this world? Isn't India the largest production base of counterfeit drugs? It is also the most arrogant and upright production base of counterfeit drugs. ”

It's no wonder that Hoffman is so angry, almost all the large drug developers in Europe and the United States have no good impression of Indians, and can even be said to hate them, for the reason mentioned earlier, that is, because the new version of the patent law promulgated in India in 1972 has a provision that has had a great impact on the Indian pharmaceutical industry: no product patents are granted for drugs, only process patents are granted for production processes, so as long as expensive drugs in European and American countries are on the market, Indian pharmaceutical companies can imitate similar products under the protection of their own laws.

Seeing that the boss was angry, Secretary Tony also echoed and said: "Boss, you are right, I was surprised when I first heard that this Indian came to buy a patent, especially since they wanted to buy the eflornithine that specializes in treating African sleeping sickness, which made me even more confused." ”

"What are you talking about? This Indian wants to buy eflornithine?" asked Hoffman incredulously.

Secretary Tony nodded: "That's right, he said that he wanted to buy eflornithine, I really don't understand, what's the use of him buying this patent, this is obviously an unprofitable business." ”

Hoffman thought for a moment, then said to his secretary, Tony, "Go and call this Indian, and I'll talk to him." ”

"Boss, you don't really want to sell it to him, do you?" asked the secretary, puzzled.

Hoffman replied disapprovingly, "If he offers the right price, why don't you sell it to him?" I do hate Indians, but I don't hate money. ”

Although Hoffman said this, his expression was still cold when Shakru came in, and he said proudly: "Mr. Pandit, I heard that you want to buy the patent rights of eflornithine developed by our company?"

Shakru nodded and replied, "That's right, what I'm going to buy is eflornithine!"

"Then I wonder what you bought eflornithine for, Mr. Panditt?" asked Hoffman curiously.

"Of course it's medicine, otherwise what else can I do?" asked Shakru with a puzzled look, but in fact, the main purpose of his purchase of eflornithine was to resell it, of course, not as a special medicine for the treatment of African sleeping sickness, but as a cosmetics.

That's right, it's cosmetics, because the word "cosmetics" that Niha Darvi inadvertently mentioned reminded him before, and finally reminded him of where he had heard the name eflornithine in his previous life, because this is also a typical case of unintentional insertion in the pharmaceutical research and development community.

In fact, about a year after the world charity negotiated with Bayer, Bayer restarted the production plan of eflornithine, of course, this is not Bayer's kindness, but they have discovered another function of eflornithine, that is, it can inhibit the growth of women's facial hair, which is a large market worth tens of billions of dollars, and Bayer is naturally reluctant to let go. At the same time, the benign response was that African people with sleeping sickness were able to borrow money to buy a cure......

Therefore, the purpose of Shaklu's visit this time is to buy the patent before Bayer discovers the effect of eflornithine in cosmetics, and then sell it to a cosmetics giant like SK to make a big profit.

Although Hoffman didn't know what Shakru really thought, he instinctively felt that something was wrong with this matter, so he asked: "Mr. Pandit, don't you know that this drug is not profitable at the moment?"

"I know, but I can't watch millions of people with sleeping sickness die because they don't have medicine, and it's just that there is no corresponding drug developed before, but now that it has been developed, there is no reason to ignore it. I know Bayer doesn't want to produce because it doesn't make a profit, but I'm not afraid, so I want to take it over!" replied Shakru with great righteousness.

Looking at Shakru's righteous and awe-inspiring appearance, Hoffman suddenly realized that this was a caring person, so he lowered his vigilance, and then asked the next question: "Then I don't know how much money you plan to pay for eflornithine Mr. Pandit?"

Shakru held up a finger and said, "A million dollars!"

Hearing this number, Hoffman was so angry that he almost laughed out loud: "Mr. Pandit, what are you kidding? Do you know how much we spent at Bayer to develop eflornithine? One million? Hehe, not even one percent! Do you think I might sell it to you so cheaply?"

Shakru retorted: "Mr. Hoffman, you are not right to say that, as far as I know, eflornithine is just a by-product of your group when developing antihypertensive drugs, and your original purpose is not for African sleeping sickness. And I don't think there will be a second person in the world other than me who will buy eflornithine, so a million dollars is a little less, but it can also make up for some of your losses!"

Hoffman snorted coldly and said, "Hmph, our Bayer is not short of this million dollars, I would rather keep it in my hands if I don't sell anyone......"

But before he could finish speaking, Shakru directly interrupted: "Then you are ready to accept the questions of charities and the media, why do you have drugs that can treat millions of African sleeping patients but do not produce them, and there are others who are willing to produce you but do not sell them, what is the purpose of your behavior? Do you have a grudge against these African sleeping patients?"